Prelude Therapeutics lands $60 million in Series B funding
Wilmington-based Prelude Therapeutics, a biotech startup that launched in 2016, has secured $60 million in Series B financing, DelawareBio has reported. The financing was co-led by…
Wilmington-based Prelude Therapeutics, a biotech startup that launched in 2016, has secured $60 million in Series B financing, DelawareBio has reported. The financing was co-led by…